84 results
8-K
EX-1.1
HROW
Harrow Inc
21 Jul 23
Harrow Prices $60 Million Public Offering of Common Stock
4:02pm
or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively
424B5
HROW
Harrow Inc
19 Jul 23
Prospectus supplement for primary offering
5:19pm
such economic downturn, volatile business environment and continued unpredictable and unstable market conditions. If the equity and credit markets deteriorate … be subject to revision at any time. Factors that can affect our credit ratings include changes in our operating performance, the economic environment, our
424B5
uh26us
18 Jul 23
Prospectus supplement for primary offering
5:03pm
8-K
EX-1.1
msljegl fgo6foh1kix
16 Dec 22
Harrow Secures Capital to Close Recently Announced Acquisition
4:40pm
8-K
EX-1.2
hrz491jg dau
16 Dec 22
Harrow Secures Capital to Close Recently Announced Acquisition
4:40pm
424B5
z7xj fi67s8h651sm
14 Dec 22
Prospectus supplement for primary offering
5:29pm
8-K
EX-10.1
77xp ctczfa6
2 Sep 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-1.1
dtmi7pyw
17 Jun 21
Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
4:15pm
8-K
EX-1.1
tqrru3
20 Apr 21
Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
4:05pm